Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: The importance of enhanced BTB and CNC homology 1 (Bach1) degradation

Journal of Nutritional Biochemistry

Volumn 25, Issue 5, 2014, Pages 515-525

  Wang, Shuai ^a   Hannafon, Bethany N ^a   Wolf, Roman F ^a   Zhou, Jundong ^b   Avery, Jori E ^a   Wu, Jinchang ^b   Lind, Stuart E ^c   Ding, Wei Qun ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant response element; Cancer; Gene transcription regulation; Heme oxygenase 1; N 3 PUFA

Indexed keywords

ACETYLCYSTEINE; BTB AND CNC HOMOLOGY 1 PROTEIN; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; HEME OXYGENASE 1; LIPID PEROXIDE; MALONALDEHYDE; NUCLEAR PROTEIN; PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; BACH1 PROTEIN, HUMAN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; FANCONI ANEMIA PROTEIN; HMOX1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID PEROXIDATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; ANIMAL; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEME OXYGENASE-1; HUMANS; LIPID PEROXIDATION; MICE, NUDE; NF-E2-RELATED FACTOR 2; PROMOTER REGIONS, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897962580     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.12.011     Document Type: Article

References (78)

1. Jiang W.G., Bryce R.P., Horrobin D.F. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 1998, 27:179-209.
2. Kang K.S., Wang P., Yamabe N., Fukui M., Jay T., Zhu B.T. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PloS One 2010, 5:e10296.
3. Hardman W.E., Barnes C.J., Knight C.W., Cameron I.L. Effects of iron supplementation and ET-18-OCH3 on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet. Br J Cancer 1997, 76:347-354.
4. Begin M.E., Ells G., Das U.N., Horrobin D.F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 1986, 77:1053-1062.
5. Karmali R.A., Marsh J., Fuchs C. Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst 1984, 73:457-461.
6. Gleissman H., Johnsen J.I., Kogner P. Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?. Exp Cell Res 2010, 316:1365-1373.
7. Stephenson J.A., Al-Taan O., Arshad A., Morgan B., Metcalfe M.S., Dennison A.R. The multifaceted effects of omega-3 polyunsaturated fatty acids on the hallmarks of cancer. J Lipids 2013, 2013:261247.
8. Jing K., Song K.S., Shin S., Kim N., Jeong S., Oh H.R., et al. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy 2011, 7:1348-1358.
9. Jakobsen C.H., Storvold G.L., Bremseth H., Follestad T., Sand K., Mack M., et al. DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis. J Lipid Res 2008, 49:2089-2100.
10. Hardman W.E., Munoz J., Cameron I.L. Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of breast cancer xenograft growth in mice. Cancer Cell Int 2002, 2:10.
11. Gonzalez M.J. Fish oil, lipid peroxidation and mammary tumor growth. J Am Coll Nutr 1995, 14:325-335.
12. Begin M.E., Ells G., Horrobin D.F. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 1988, 80:188-194.
13. Srisook K., Kim C., Cha Y.N. Molecular mechanisms involved in enhancing HO-1 expression: de-repression by heme and activation by Nrf2, the "one-two" punch. Antioxid Redox Signal 2005, 7:1674-1687.
14. Gozzelino R., Jeney V., Soares M.P. Mechanisms of cell protection by heme oxygenase-1. Ann Rev Pharmacol Toxicol 2010, 50:323-354.
15. Wright M.M., Schopfer F.J., Baker P.R., Vidyasagar V., Powell P., Chumley P., et al. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc Natl Acad Sci U S A 2006, 103:4299-4304.
16. Lu D.Y., Tsao Y.Y., Leung Y.M., Su K.P. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology 2010, 35:2238-2248.
17. Wang H., Khor T.O., Saw C.L., Lin W., Wu T., Huang Y., et al. Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Mol Pharm 2010, 7:2185-2193.
18. Brown N.S., Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 2001, 3:323-327.
19. Zhou Y., Hileman E.O., Plunkett W., Keating M.J., Huang P. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 2003, 101:4098-4104.
20. Schor N.F., Kagan V.E., Liang Y., Yan C., Tyurina Y., Tyurin V., et al. Exploiting oxidative stress and signaling in chemotherapy of resistant neoplasms. Biochemistry (Mosc) 2004, 69:38-44.
21. Nuhn P., Kunzli B.M., Hennig R., Mitkus T., Ramanauskas T., Nobiling R., et al. Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer 2009, 8:37.
22. Gleixner K.V., Mayerhofer M., Vales A., Gruze A., Hormann G., Cerny-Reiterer S., et al. Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy. Curr Cancer Drug Targets 2009, 9:675-689.
23. Louie K.G., Behrens B.C., Kinsella T.J., Hamilton T.C., Grotzinger K.R., McKoy W.M., et al. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res 1985, 45:2110-2115.
24. van Oost B.A., Edgell C.J., Hay C.W., MacGillivray R.T. Isolation of a human von Willebrand factor cDNA from the hybrid endothelial cell line EA.hy926. Biochem Cell Biol 1986, 64:699-705.
25. Boudreau M.D., Sohn K.H., Rhee S.H., Lee S.W., Hunt J.D., Hwang D.H. Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways. Cancer Res 2001, 61:1386-1391.
26. Reddy B.S., Maruyama H. Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res 1986, 46:3367-3370.
27. Rose D.P., Connolly J.M. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice. J Natl Cancer Inst 1993, 85:1743-1747.
28. Kelavkar U.P., Hutzley J., McHugh K., Allen K.G., Parwani A. Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes. Neoplasia 2009, 11:692-699.
29. Akinsete J.A., Ion G., Witte T.R., Hardman W.E. Consumption of high omega-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis 2012, 33:140-148.
30. Ding W.Q., Liu B., Vaught J.L., Yamauchi H., Lind S.E. Anticancer activity of the antibiotic clioquinol. Cancer Res 2005, 65:3389-3395.
31. Zhou J., Zhang S., Xue J., Avery J., Wu J., Lind S.E., et al. Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) suppresses hypoxia-inducible factor-1alpha (HIF-1alpha) signaling in cancer cells. J Biol Chem 2012, 287:35161-35169.
32. Ding W.Q., Vaught J.L., Yamauchi H., Lind S.E. Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression. Mol Cancer Ther 2004, 3:1109-1117.
33. Rushworth S.A., Chen X.L., Mackman N., Ogborne R.M., O'Connell M.A. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol 2005, 175:4408-4415.
34. Rushworth S.A., MacEwan D.J. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood 2008, 111:3793-3801.
35. Kronke G., Kadl A., Ikonomu E., Bluml S., Furnkranz A., Sarembock I.J., et al. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 2007, 27:1276-1282.
36. Xue J., Wang S., Wu J., Hannafon B.N., Ding W.Q. Zinc at sub-cytotoxic concentrations induces heme oxygenase-1 expression in human cancer cells. Cell Physiol Biochem 2013, 32:100-110.
37. Chen H.H., Chen T.W., Lin H. Pravastatin attenuates carboplatin-induced nephrotoxicity in rodents via peroxisome proliferator-activated receptor alpha-regulated heme oxygenase-1. Mol Pharmacol 2010, 78:36-45.
38. Huang H., Starodub O., McIntosh A., Kier A.B., Schroeder F. Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem 2002, 277:29139-29151.
39. Tuller E.R., Beavers C.T., Lou J.R., Ihnat M.A., Benbrook D.M., Ding W.Q. Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. Mol Pharmacol 2009, 76:588-595.
40. Tuller E.R., Brock A.L., Yu H., Lou J.R., Benbrook D.M., Ding W.Q. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem Pharmacol 2009, 77:1480-1486.
41. Wright M.M., Kim J., Hock T.D., Leitinger N., Freeman B.A., Agarwal A. Human haem oxygenase-1 induction by nitro-linoleic acid is mediated by cAMP, AP-1 and E-box response element interactions. Biochem J 2009, 422:353-361.
42. Yang Y.C., Lii C.K., Wei Y.L., Li C.C., Lu C.Y., Liu K.L., et al. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-kappaB pathways. J Nutr Biochem 2013, 24:204-212.
43. Ishikado A., Morino K., Nishio Y., Nakagawa F., Mukose A., Sono Y., et al. 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation. PloS One 2013, 8:e69415.
44. Sun J., Hoshino H., Takaku K., Nakajima O., Muto A., Suzuki H., et al. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. Embo J 2002, 21:5216-5224.
45. Raval C.M., Zhong J.L., Mitchell S.A., Tyrrell R.M. The role of Bach1 in ultraviolet A-mediated human heme oxygenase 1 regulation in human skin fibroblasts. Free Radic Biol Med 2012, 52:227-236.
46. Hou W., Shan Y., Zheng J., Lambrecht R.W., Donohue S.E., Bonkovsky H.L. Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1. Biochim Biophys Acta 2008, 1779:195-203.
47. Nardinocchi L., Pantisano V., Puca R., Porru M., Aiello A., Grasselli A., et al. Zinc downregulates HIF-1alpha and inhibits its activity in tumor cells in vitro and in vivo. PloS One 2010, 5:e15048.
48. Birle D.C., Hedley D.W. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors. Cancer Res 2007, 67:1735-1743.
49. Ding W.Q., Lind S.E. Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. Mol Cancer Ther 2007, 6:1467-1474.
50. Ng Y., Barhoumi R., Tjalkens R.B., Fan Y.Y., Kolar S., Wang N., et al. The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis 2005, 26:1914-1921.
51. Merendino N., Loppi B., D'Aquino M., Molinari R., Pessina G., Romano C., et al. Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr Cancer 2005, 52:225-233.
52. Leonardi F., Attorri L., Di Benedetto R., Di Biase A., Sanchez M., Nardini M., et al. Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells. Free Radic Res 2005, 39:865-874.
53. Collett E.D., Davidson L.A., Fan Y.Y., Lupton J.R., Chapkin R.S. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol 2001, 280:C1066-C1075.
54. Xue M., Wang Q., Zhao J., Dong L., Ge Y., Hou L., et al. Docosahexaenoic acid inhibited the Wnt/beta-catenin pathway and suppressed breast cancer cells in vitro and in vivo. J Nutr Biochem 2014, 25:104-110.
55. Gleissman H., Segerstrom L., Hamberg M., Ponthan F., Lindskog M., Johnsen J.I., et al. Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo. Int J Cancer 2011, 128:1703-1711.
56. Burns C.P., Halabi S., Clamon G.H., Hars V., Wagner B.A., Hohl R.J., et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res 1999, 5:3942-3947.
57. Garg M.L., Leitch J., Blake R.J., Garg R. Long-chain n-3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation. Lipids 2006, 41:1127-1132.
58. Kuriki K., Nagaya T., Tokudome Y., Imaeda N., Fujiwara N., Sato J., et al. Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr 2003, 133:3643-3650.
59. Thiebaut A.C., Rotival M., Gauthier E., Lenoir G.M., Boutron-Ruault M.C., Joulin V., et al. Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier. Nutr Cancer 2009, 61:500-509.
60. Brasky T.M., Darke A.K., Song X., Tangen C.M., Goodman P.J., Thompson I.M., et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 2013, 105:1132-1141.
61. Chen H.W., Chao C.Y., Lin L.L., Lu C.Y., Liu K.L., Lii C.K., et al. Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells. Arch Toxicol 2013, 87:857-869.
62. Saw C.L., Yang A.Y., Guo Y., Kong A.N. Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway. Food Chem Toxicol 2013, 62:869-875.
63. Wang S., Avery J.E., Hannafon B.N., Lind S.E., Ding W.Q. Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: the involvement of the Wnt/beta-catenin signaling pathway. Biochem Pharmacol 2013, 85:1611-1618.
64. Das U.N. Essential fatty acids - a review. Curr Pharm Biotechnol 2006, 7:467-482.
65. Merchant A.A., Singh A., Matsui W., Biswal S. The redox-sensitive transcription factor Nrf2 regulates murine hematopoietic stem cell survival independently of ROS levels. Blood 2011, 118:6572-6579.
66. Lee J.M., Moehlenkamp J.D., Hanson J.M., Johnson J.A. Nrf2-dependent activation of the antioxidant responsive element by tert-butylhydroquinone is independent of oxidative stress in IMR-32 human neuroblastoma cells. Biochem Biophys Res Commun 2001, 280:286-292.
67. Shan Y., Lambrecht R.W., Donohue S.E., Bonkovsky H.L. Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J 2006, 20:2651-2653.
68. Bougnoux P. n-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 1999, 2:121-126.
69. Hardman W.E. (n-3) fatty acids and cancer therapy. J Nutr 2004, 134:3427S-3430S.
70. Maheo K., Vibet S., Steghens J.P., Dartigeas C., Lehman M., Bougnoux P., et al. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic Biol Med 2005, 39:742-751.
71. Siddiqui R.A., Harvey K., Stillwell W. Anticancer properties of oxidation products of docosahexaenoic acid. Chem Phys Lipids 2008, 153:47-56.
72. Siddiqui R.A., Harvey K.A., Xu Z., Bammerlin E.M., Walker C., Altenburg J.D. Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. Biofactors 2011, 37:399-412.
73. Barbagallo I., Galvano F., Frigiola A., Cappello F., Riccioni G., Murabito P., et al. Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox Signal 2013, 18:507-521.
74. Durante W. Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front Biosci 2011, 16:2372-2388.
75. Was H., Dulak J., Jozkowicz A. Heme oxygenase-1 in tumor biology and therapy. Curr Drug Targets 2010, 11:1551-1570.
76. Fang J., Sawa T., Akaike T., Akuta T., Sahoo S.K., Khaled G., et al. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res 2003, 63:3567-3574.
77. Hirai K., Sasahira T., Ohmori H., Fujii K., Kuniyasu H. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 2007, 120:500-505.
78. La P., Fernando A.P., Wang Z., Salahudeen A., Yang G., Lin Q., et al. Zinc protoporphyrin regulates cyclin D1 expression independent of heme oxygenase inhibition. J Biol Chem 2009, 284:36302-36311.